Project
Illumina Body Map 2
Navigation
Downloads
Results for SP3
Z-value: 2.25
Motif logo
Transcription factors associated with SP3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP3
|
ENSG00000172845.9 | Sp3 transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP3 | hg19_v2_chr2_-_174830430_174830563 | 0.18 | 3.3e-01 | Click! |
Activity profile of SP3 motif
Sorted Z-values of SP3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr11_+_2466218 | 8.66 |
ENST00000155840.5
|
KCNQ1
|
potassium voltage-gated channel, KQT-like subfamily, member 1 |
| chr12_+_6419877 | 6.66 |
ENST00000536531.1
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
| chr22_-_50746027 | 6.65 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
| chr18_+_11981427 | 6.53 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr16_+_1203194 | 6.36 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
| chr22_-_50746001 | 6.03 |
ENST00000359337.4
|
PLXNB2
|
plexin B2 |
| chr18_+_11981547 | 6.02 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr14_+_104552016 | 5.54 |
ENST00000551177.1
ENST00000546892.2 ENST00000455920.2 |
ASPG
|
asparaginase homolog (S. cerevisiae) |
| chr18_+_11981014 | 5.53 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr21_+_35445827 | 5.44 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
| chr21_-_42879909 | 5.37 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
| chr16_-_66952779 | 5.37 |
ENST00000570262.1
ENST00000394055.3 ENST00000299752.4 |
CDH16
|
cadherin 16, KSP-cadherin |
| chr17_+_81037473 | 5.31 |
ENST00000320095.7
|
METRNL
|
meteorin, glial cell differentiation regulator-like |
| chr14_-_21566731 | 5.20 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr7_-_149470297 | 4.92 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
| chr22_-_43583079 | 4.62 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
| chr9_-_97401782 | 4.61 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr21_-_42880075 | 4.58 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
| chr20_-_52210368 | 4.52 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
| chr1_+_955448 | 4.52 |
ENST00000379370.2
|
AGRN
|
agrin |
| chr7_+_5322561 | 4.49 |
ENST00000396872.3
ENST00000444741.1 ENST00000297195.4 ENST00000406453.3 |
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4 |
| chr11_+_45944190 | 4.47 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
| chr18_+_29078131 | 4.46 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr9_-_139581848 | 4.46 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr12_+_52626898 | 4.46 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
| chr11_+_289155 | 4.45 |
ENST00000409655.1
|
ATHL1
|
ATH1, acid trehalase-like 1 (yeast) |
| chr16_+_67465016 | 4.45 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
| chr19_-_39226045 | 4.38 |
ENST00000597987.1
ENST00000595177.1 |
CAPN12
|
calpain 12 |
| chr1_+_16375284 | 4.36 |
ENST00000375667.3
|
CLCNKB
|
chloride channel, voltage-sensitive Kb |
| chr16_+_29817399 | 4.36 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr1_+_33207381 | 4.33 |
ENST00000401073.2
|
KIAA1522
|
KIAA1522 |
| chr15_-_90358048 | 4.31 |
ENST00000300060.6
ENST00000560137.1 |
ANPEP
|
alanyl (membrane) aminopeptidase |
| chr4_-_1166623 | 4.30 |
ENST00000290902.5
|
SPON2
|
spondin 2, extracellular matrix protein |
| chr21_+_46825032 | 4.27 |
ENST00000400337.2
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chr3_+_154797428 | 4.24 |
ENST00000460393.1
|
MME
|
membrane metallo-endopeptidase |
| chr21_+_42688686 | 4.17 |
ENST00000398652.3
ENST00000398647.3 |
FAM3B
|
family with sequence similarity 3, member B |
| chr9_-_130331297 | 4.17 |
ENST00000373312.3
|
FAM129B
|
family with sequence similarity 129, member B |
| chr16_-_66952742 | 4.16 |
ENST00000565235.2
ENST00000568632.1 ENST00000565796.1 |
CDH16
|
cadherin 16, KSP-cadherin |
| chr16_+_77246337 | 4.12 |
ENST00000563157.1
|
SYCE1L
|
synaptonemal complex central element protein 1-like |
| chr17_+_79761997 | 4.11 |
ENST00000400723.3
ENST00000570996.1 |
GCGR
|
glucagon receptor |
| chr17_+_7788104 | 4.08 |
ENST00000380358.4
|
CHD3
|
chromodomain helicase DNA binding protein 3 |
| chr2_+_47596287 | 4.06 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr18_+_29077990 | 4.05 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
| chr3_+_37903432 | 3.98 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
| chr11_+_706113 | 3.96 |
ENST00000318562.8
ENST00000533256.1 ENST00000534755.1 |
EPS8L2
|
EPS8-like 2 |
| chr15_+_41136216 | 3.95 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr17_-_7164410 | 3.89 |
ENST00000574070.1
|
CLDN7
|
claudin 7 |
| chr9_+_116638630 | 3.85 |
ENST00000452710.1
ENST00000374124.4 |
ZNF618
|
zinc finger protein 618 |
| chr15_+_80445232 | 3.85 |
ENST00000561421.1
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| chr4_-_1166954 | 3.84 |
ENST00000514490.1
ENST00000431380.1 ENST00000503765.1 |
SPON2
|
spondin 2, extracellular matrix protein |
| chr19_-_11529225 | 3.83 |
ENST00000567431.1
|
RGL3
|
ral guanine nucleotide dissociation stimulator-like 3 |
| chr15_+_41136586 | 3.83 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr9_-_139581875 | 3.81 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr2_+_10091815 | 3.80 |
ENST00000324907.9
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr5_+_78407602 | 3.79 |
ENST00000274353.5
ENST00000524080.1 |
BHMT
|
betaine--homocysteine S-methyltransferase |
| chr2_+_10091783 | 3.78 |
ENST00000324883.5
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr15_-_54051831 | 3.76 |
ENST00000557913.1
ENST00000360509.5 |
WDR72
|
WD repeat domain 72 |
| chr21_+_44394742 | 3.76 |
ENST00000432907.2
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
| chr11_+_289110 | 3.76 |
ENST00000409548.2
|
ATHL1
|
ATH1, acid trehalase-like 1 (yeast) |
| chr2_+_120189422 | 3.75 |
ENST00000306406.4
|
TMEM37
|
transmembrane protein 37 |
| chr2_+_238600788 | 3.72 |
ENST00000289175.6
ENST00000244815.5 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr20_-_22565101 | 3.70 |
ENST00000419308.2
|
FOXA2
|
forkhead box A2 |
| chr15_+_41136369 | 3.67 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr11_-_6677018 | 3.65 |
ENST00000299441.3
|
DCHS1
|
dachsous cadherin-related 1 |
| chr3_-_185542761 | 3.65 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr8_-_144815966 | 3.58 |
ENST00000388913.3
|
FAM83H
|
family with sequence similarity 83, member H |
| chr12_-_6483969 | 3.57 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr11_+_2923423 | 3.51 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
| chrX_+_109245863 | 3.51 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
| chr12_-_54982300 | 3.50 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr3_-_185542817 | 3.49 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr2_+_105471969 | 3.47 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr15_+_80445113 | 3.46 |
ENST00000407106.1
ENST00000261755.5 |
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| chr13_-_114018400 | 3.45 |
ENST00000375430.4
ENST00000375431.4 |
GRTP1
|
growth hormone regulated TBC protein 1 |
| chr15_-_65067773 | 3.45 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
| chr11_+_130029457 | 3.45 |
ENST00000278742.5
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma) |
| chr5_-_2751762 | 3.44 |
ENST00000302057.5
ENST00000382611.6 |
IRX2
|
iroquois homeobox 2 |
| chr20_-_52790055 | 3.42 |
ENST00000395955.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr10_-_126849068 | 3.42 |
ENST00000494626.2
ENST00000337195.5 |
CTBP2
|
C-terminal binding protein 2 |
| chr1_-_22263790 | 3.39 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr11_-_70963538 | 3.39 |
ENST00000413503.1
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
| chr20_+_62371206 | 3.35 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
| chrX_-_3631635 | 3.34 |
ENST00000262848.5
|
PRKX
|
protein kinase, X-linked |
| chr12_-_6484376 | 3.33 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr7_-_148725733 | 3.32 |
ENST00000286091.4
|
PDIA4
|
protein disulfide isomerase family A, member 4 |
| chr16_+_56691911 | 3.31 |
ENST00000568475.1
|
MT1F
|
metallothionein 1F |
| chr6_+_132129151 | 3.30 |
ENST00000360971.2
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
| chr19_+_17905919 | 3.28 |
ENST00000318683.6
ENST00000600777.1 ENST00000595387.1 |
B3GNT3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
| chr6_+_54711533 | 3.28 |
ENST00000306858.7
|
FAM83B
|
family with sequence similarity 83, member B |
| chrX_-_2847366 | 3.27 |
ENST00000381154.1
|
ARSD
|
arylsulfatase D |
| chr16_+_55357672 | 3.27 |
ENST00000290552.7
|
IRX6
|
iroquois homeobox 6 |
| chr3_-_194207388 | 3.26 |
ENST00000457986.1
|
ATP13A3
|
ATPase type 13A3 |
| chr2_+_27665232 | 3.24 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
| chr11_-_93276514 | 3.20 |
ENST00000526869.1
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
| chr19_-_2015699 | 3.20 |
ENST00000255608.4
|
BTBD2
|
BTB (POZ) domain containing 2 |
| chr11_-_441964 | 3.19 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
| chr1_-_2126192 | 3.18 |
ENST00000378546.4
|
C1orf86
|
chromosome 1 open reading frame 86 |
| chr21_-_40720995 | 3.17 |
ENST00000380749.5
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
| chr1_-_150946911 | 3.17 |
ENST00000457392.1
ENST00000421609.1 |
CERS2
|
ceramide synthase 2 |
| chr9_+_116638562 | 3.16 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
| chr19_+_18284477 | 3.16 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
| chr20_-_62462566 | 3.13 |
ENST00000245663.4
ENST00000302995.2 |
ZBTB46
|
zinc finger and BTB domain containing 46 |
| chr3_+_12329397 | 3.10 |
ENST00000397015.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
| chr17_-_7165662 | 3.08 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr2_-_10220538 | 3.07 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
| chr22_-_37915247 | 3.05 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
| chr1_-_150947299 | 3.04 |
ENST00000361419.5
|
CERS2
|
ceramide synthase 2 |
| chr7_+_73242490 | 3.04 |
ENST00000431918.1
|
CLDN4
|
claudin 4 |
| chr10_+_82214010 | 3.04 |
ENST00000481124.1
|
TSPAN14
|
tetraspanin 14 |
| chr2_+_11295498 | 3.02 |
ENST00000295083.3
ENST00000441908.2 |
PQLC3
|
PQ loop repeat containing 3 |
| chr3_-_46735132 | 3.02 |
ENST00000415953.1
|
ALS2CL
|
ALS2 C-terminal like |
| chr3_+_53195517 | 3.00 |
ENST00000487897.1
|
PRKCD
|
protein kinase C, delta |
| chr14_+_24563262 | 3.00 |
ENST00000559250.1
ENST00000216780.4 ENST00000560736.1 ENST00000396973.4 ENST00000559837.1 |
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
| chr19_-_51327034 | 3.00 |
ENST00000301420.2
ENST00000448701.2 |
KLK1
|
kallikrein 1 |
| chr17_-_7167279 | 2.99 |
ENST00000571932.2
|
CLDN7
|
claudin 7 |
| chr8_+_95653373 | 2.99 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr2_+_10183651 | 2.99 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
| chr22_+_45064593 | 2.98 |
ENST00000432186.1
|
PRR5
|
proline rich 5 (renal) |
| chr19_-_51412584 | 2.98 |
ENST00000431178.2
|
KLK4
|
kallikrein-related peptidase 4 |
| chr2_+_11295624 | 2.98 |
ENST00000402361.1
ENST00000428481.1 |
PQLC3
|
PQ loop repeat containing 3 |
| chr21_-_44846999 | 2.97 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr11_+_2923619 | 2.97 |
ENST00000380574.1
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr19_+_55587266 | 2.96 |
ENST00000201647.6
ENST00000540810.1 |
EPS8L1
|
EPS8-like 1 |
| chr3_+_154797636 | 2.96 |
ENST00000481828.1
|
MME
|
membrane metallo-endopeptidase |
| chr5_+_2752334 | 2.95 |
ENST00000505778.1
ENST00000515640.1 ENST00000397835.4 |
C5orf38
|
chromosome 5 open reading frame 38 |
| chr15_+_41136263 | 2.95 |
ENST00000568823.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr17_-_7166500 | 2.95 |
ENST00000575313.1
ENST00000397317.4 |
CLDN7
|
claudin 7 |
| chr3_-_53290016 | 2.94 |
ENST00000423525.2
ENST00000423516.1 ENST00000296289.6 ENST00000462138.1 |
TKT
|
transketolase |
| chr19_-_33555780 | 2.92 |
ENST00000254260.3
ENST00000400226.4 |
RHPN2
|
rhophilin, Rho GTPase binding protein 2 |
| chr7_-_73184588 | 2.91 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr7_-_149470540 | 2.91 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
| chr8_+_19171487 | 2.91 |
ENST00000519207.1
|
SH2D4A
|
SH2 domain containing 4A |
| chr3_-_128840604 | 2.90 |
ENST00000476465.1
ENST00000315150.5 ENST00000393304.1 ENST00000393308.1 ENST00000393307.1 ENST00000393305.1 |
RAB43
|
RAB43, member RAS oncogene family |
| chr17_+_42081914 | 2.89 |
ENST00000293404.3
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
| chr15_+_41136734 | 2.89 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr7_-_148725544 | 2.88 |
ENST00000413966.1
|
PDIA4
|
protein disulfide isomerase family A, member 4 |
| chr19_+_54371114 | 2.88 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr3_+_154797877 | 2.87 |
ENST00000462745.1
ENST00000493237.1 |
MME
|
membrane metallo-endopeptidase |
| chr3_-_27525826 | 2.87 |
ENST00000454389.1
ENST00000440156.1 ENST00000437179.1 ENST00000446700.1 ENST00000455077.1 ENST00000435667.2 ENST00000388777.4 ENST00000425128.2 |
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
| chr11_+_46403303 | 2.87 |
ENST00000407067.1
ENST00000395565.1 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr22_-_37415475 | 2.86 |
ENST00000403892.3
ENST00000249042.3 ENST00000438203.1 |
TST
|
thiosulfate sulfurtransferase (rhodanese) |
| chr2_+_27665289 | 2.86 |
ENST00000407293.1
|
KRTCAP3
|
keratinocyte associated protein 3 |
| chr3_-_46735155 | 2.85 |
ENST00000318962.4
|
ALS2CL
|
ALS2 C-terminal like |
| chr2_-_20424844 | 2.84 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
| chrX_+_9433289 | 2.83 |
ENST00000422314.1
|
TBL1X
|
transducin (beta)-like 1X-linked |
| chr8_+_95653302 | 2.83 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chrX_+_117629766 | 2.82 |
ENST00000276204.6
ENST00000276202.7 |
DOCK11
|
dedicator of cytokinesis 11 |
| chr7_+_150497569 | 2.82 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
| chr16_-_31147020 | 2.82 |
ENST00000568261.1
ENST00000567797.1 ENST00000317508.6 |
PRSS8
|
protease, serine, 8 |
| chr16_-_54320675 | 2.81 |
ENST00000329734.3
|
IRX3
|
iroquois homeobox 3 |
| chr11_+_2482661 | 2.81 |
ENST00000335475.5
|
KCNQ1
|
potassium voltage-gated channel, KQT-like subfamily, member 1 |
| chr21_-_40720974 | 2.80 |
ENST00000380748.1
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
| chr12_-_53297432 | 2.80 |
ENST00000546900.1
|
KRT8
|
keratin 8 |
| chr5_-_180237445 | 2.80 |
ENST00000393340.3
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr17_+_48712206 | 2.79 |
ENST00000427699.1
ENST00000285238.8 |
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
| chr14_-_38064198 | 2.78 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
| chr10_-_135171178 | 2.78 |
ENST00000368551.1
|
FUOM
|
fucose mutarotase |
| chr12_-_106641728 | 2.77 |
ENST00000378026.4
|
CKAP4
|
cytoskeleton-associated protein 4 |
| chr11_+_706595 | 2.77 |
ENST00000531348.1
ENST00000530636.1 |
EPS8L2
|
EPS8-like 2 |
| chr10_+_11784360 | 2.77 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chr21_+_44394620 | 2.77 |
ENST00000291547.5
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
| chr2_-_113993020 | 2.75 |
ENST00000465084.1
|
PAX8
|
paired box 8 |
| chr21_+_44073860 | 2.75 |
ENST00000335512.4
ENST00000539837.1 ENST00000291539.6 ENST00000380328.2 ENST00000398232.3 ENST00000398234.3 ENST00000398236.3 ENST00000328862.6 ENST00000335440.6 ENST00000398225.3 ENST00000398229.3 ENST00000398227.3 |
PDE9A
|
phosphodiesterase 9A |
| chr16_+_23194033 | 2.75 |
ENST00000300061.2
|
SCNN1G
|
sodium channel, non-voltage-gated 1, gamma subunit |
| chr19_+_45281118 | 2.75 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr2_+_47596634 | 2.75 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
| chr11_-_93276582 | 2.75 |
ENST00000298966.2
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
| chr6_+_168227611 | 2.74 |
ENST00000344191.4
ENST00000351017.4 ENST00000392108.3 ENST00000366806.2 ENST00000392112.1 ENST00000400824.4 ENST00000447894.2 ENST00000400822.3 |
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
| chr6_+_1312675 | 2.73 |
ENST00000296839.2
|
FOXQ1
|
forkhead box Q1 |
| chr9_+_137218362 | 2.72 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
| chr11_+_134201911 | 2.71 |
ENST00000389881.3
|
GLB1L2
|
galactosidase, beta 1-like 2 |
| chr10_+_135122906 | 2.71 |
ENST00000368554.4
|
ZNF511
|
zinc finger protein 511 |
| chr6_+_12012170 | 2.71 |
ENST00000487103.1
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
| chr3_-_176915215 | 2.71 |
ENST00000457928.2
ENST00000422442.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr19_-_11530012 | 2.71 |
ENST00000380456.3
|
RGL3
|
ral guanine nucleotide dissociation stimulator-like 3 |
| chr21_+_42688657 | 2.70 |
ENST00000357985.2
|
FAM3B
|
family with sequence similarity 3, member B |
| chr9_-_33167308 | 2.69 |
ENST00000535206.1
ENST00000379731.4 |
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
| chr2_-_197036289 | 2.68 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
| chr1_-_71513471 | 2.68 |
ENST00000370931.3
ENST00000356595.4 ENST00000306666.5 ENST00000370932.2 ENST00000351052.5 ENST00000414819.1 ENST00000370924.4 |
PTGER3
|
prostaglandin E receptor 3 (subtype EP3) |
| chr16_-_2908155 | 2.67 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
| chr17_-_1389419 | 2.67 |
ENST00000575158.1
|
MYO1C
|
myosin IC |
| chr1_+_209848749 | 2.67 |
ENST00000367029.4
|
G0S2
|
G0/G1switch 2 |
| chr11_+_134201768 | 2.67 |
ENST00000535456.2
ENST00000339772.7 |
GLB1L2
|
galactosidase, beta 1-like 2 |
| chr1_+_9294822 | 2.67 |
ENST00000377403.2
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
| chr9_+_140317802 | 2.67 |
ENST00000341349.2
ENST00000392815.2 |
NOXA1
|
NADPH oxidase activator 1 |
| chr2_+_238600933 | 2.67 |
ENST00000420665.1
ENST00000392000.4 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr4_-_1107306 | 2.66 |
ENST00000433731.2
ENST00000333673.5 ENST00000382968.5 |
RNF212
|
ring finger protein 212 |
| chr2_+_219264762 | 2.65 |
ENST00000452977.1
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr11_+_64073022 | 2.65 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
| chr8_-_11725549 | 2.64 |
ENST00000505496.2
ENST00000534636.1 ENST00000524500.1 ENST00000345125.3 ENST00000453527.2 ENST00000527215.2 ENST00000532392.1 ENST00000533455.1 ENST00000534510.1 ENST00000530640.2 ENST00000531089.1 ENST00000532656.2 ENST00000531502.1 ENST00000434271.1 ENST00000353047.6 |
CTSB
|
cathepsin B |
| chr19_+_50015870 | 2.64 |
ENST00000599701.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
| chr2_-_20425158 | 2.64 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
| chr1_+_31886653 | 2.63 |
ENST00000536384.1
|
SERINC2
|
serine incorporator 2 |
| chr12_-_54982420 | 2.62 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr19_+_55591743 | 2.62 |
ENST00000588359.1
ENST00000245618.5 |
EPS8L1
|
EPS8-like 1 |
| chr11_+_64949158 | 2.62 |
ENST00000527739.1
ENST00000526966.1 ENST00000533129.1 ENST00000524773.1 |
CAPN1
|
calpain 1, (mu/I) large subunit |
| chr1_-_16532985 | 2.61 |
ENST00000441785.1
ENST00000449495.1 |
ARHGEF19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
| chr5_+_2752258 | 2.61 |
ENST00000334000.3
|
C5orf38
|
chromosome 5 open reading frame 38 |
| chr11_+_65082289 | 2.61 |
ENST00000279249.2
|
CDC42EP2
|
CDC42 effector protein (Rho GTPase binding) 2 |
| chr17_-_1389228 | 2.60 |
ENST00000438665.2
|
MYO1C
|
myosin IC |
Network of associatons between targets according to the STRING database.
First level regulatory network of SP3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 8.7 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 2.2 | 2.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 2.1 | 18.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 2.1 | 6.2 | GO:0003192 | mitral valve formation(GO:0003192) |
| 2.0 | 11.8 | GO:0030421 | defecation(GO:0030421) |
| 2.0 | 7.9 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 2.0 | 7.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 2.0 | 5.9 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 1.9 | 5.8 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 1.8 | 1.8 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 1.8 | 5.3 | GO:0048627 | myoblast development(GO:0048627) |
| 1.7 | 5.2 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.7 | 6.9 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.7 | 5.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 1.7 | 8.5 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 1.7 | 6.7 | GO:0044691 | tooth eruption(GO:0044691) |
| 1.7 | 14.9 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 1.6 | 4.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 1.6 | 6.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 1.6 | 9.8 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 1.6 | 6.4 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.6 | 4.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.5 | 7.7 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.5 | 7.7 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.5 | 6.1 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 1.5 | 6.0 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.5 | 7.5 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 1.4 | 4.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 1.4 | 1.4 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 1.4 | 4.2 | GO:1903570 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.4 | 5.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 1.4 | 8.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.4 | 5.5 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 1.4 | 5.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.3 | 1.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 1.3 | 3.9 | GO:0052251 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.3 | 6.5 | GO:0015862 | uridine transport(GO:0015862) |
| 1.3 | 9.0 | GO:0097473 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.3 | 1.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 1.3 | 3.8 | GO:1990575 | mitochondrial L-ornithine transmembrane transport(GO:1990575) |
| 1.3 | 8.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 1.3 | 3.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 1.2 | 3.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.2 | 3.7 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 1.2 | 3.7 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
| 1.2 | 3.6 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 1.2 | 6.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 1.2 | 15.7 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 1.2 | 1.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 1.2 | 1.2 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
| 1.2 | 3.5 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.2 | 4.7 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 1.2 | 5.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 1.2 | 1.2 | GO:0060179 | male mating behavior(GO:0060179) |
| 1.1 | 3.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.1 | 10.2 | GO:0046618 | drug export(GO:0046618) |
| 1.1 | 9.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.1 | 29.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.1 | 16.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.1 | 18.9 | GO:0002934 | desmosome organization(GO:0002934) |
| 1.1 | 5.5 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 1.1 | 3.3 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 1.1 | 1.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 1.1 | 7.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.1 | 4.3 | GO:0051413 | response to cortisone(GO:0051413) |
| 1.1 | 3.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 1.1 | 8.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 1.1 | 4.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.1 | 7.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.1 | 2.1 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 1.1 | 4.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 1.1 | 4.2 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.0 | 5.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.0 | 9.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 1.0 | 2.1 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 1.0 | 2.1 | GO:0009644 | response to high light intensity(GO:0009644) |
| 1.0 | 4.1 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 1.0 | 10.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.0 | 13.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 1.0 | 9.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.0 | 3.0 | GO:0071423 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 1.0 | 2.0 | GO:1904385 | cellular response to angiotensin(GO:1904385) |
| 1.0 | 1.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 1.0 | 3.0 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.0 | 3.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 1.0 | 3.0 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 1.0 | 2.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 1.0 | 1.9 | GO:1901656 | glycoside transport(GO:1901656) |
| 1.0 | 15.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.0 | 5.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.0 | 3.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.0 | 2.9 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 1.0 | 4.8 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 1.0 | 6.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.9 | 1.9 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
| 0.9 | 2.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.9 | 4.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.9 | 2.8 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.9 | 3.8 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.9 | 0.9 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.9 | 5.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.9 | 0.9 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.9 | 0.9 | GO:0009798 | axis specification(GO:0009798) |
| 0.9 | 2.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.9 | 2.8 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.9 | 14.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.9 | 0.9 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.9 | 5.6 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.9 | 2.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.9 | 4.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.9 | 1.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.9 | 1.9 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.9 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.9 | 2.7 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.9 | 6.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.9 | 2.7 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.9 | 2.7 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.9 | 3.6 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.9 | 2.7 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.9 | 2.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.9 | 9.6 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.9 | 4.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.9 | 0.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.9 | 3.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.9 | 6.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.9 | 12.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.9 | 2.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.9 | 0.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.8 | 2.5 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.8 | 3.4 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.8 | 5.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.8 | 5.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.8 | 7.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.8 | 3.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.8 | 2.5 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.8 | 4.2 | GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
| 0.8 | 3.3 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
| 0.8 | 2.5 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.8 | 3.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.8 | 4.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.8 | 3.2 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.8 | 6.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.8 | 3.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.8 | 4.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.8 | 2.4 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
| 0.8 | 3.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.8 | 2.4 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.8 | 2.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.8 | 4.0 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.8 | 2.4 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.8 | 0.8 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.8 | 4.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.8 | 3.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.8 | 3.2 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.8 | 2.4 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.8 | 10.3 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.8 | 3.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.8 | 2.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.8 | 1.6 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.8 | 3.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.8 | 0.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.8 | 1.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.8 | 5.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.8 | 2.3 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.8 | 3.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.8 | 3.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.8 | 2.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.8 | 1.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.8 | 3.8 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.8 | 0.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.8 | 0.8 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.8 | 5.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.8 | 2.3 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.8 | 0.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.8 | 7.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.7 | 5.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.7 | 27.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.7 | 2.2 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.7 | 2.2 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.7 | 2.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.7 | 0.7 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.7 | 0.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.7 | 0.7 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.7 | 2.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.7 | 1.5 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.7 | 0.7 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.7 | 0.7 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.7 | 2.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.7 | 0.7 | GO:0031929 | TOR signaling(GO:0031929) |
| 0.7 | 2.9 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.7 | 5.1 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.7 | 11.6 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.7 | 2.9 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
| 0.7 | 2.9 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.7 | 2.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.7 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.7 | 2.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.7 | 0.7 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
| 0.7 | 3.6 | GO:0000050 | urea cycle(GO:0000050) |
| 0.7 | 4.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.7 | 0.7 | GO:0046887 | positive regulation of hormone secretion(GO:0046887) |
| 0.7 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.7 | 3.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.7 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.7 | 0.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.7 | 6.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.7 | 0.7 | GO:0060022 | hard palate development(GO:0060022) |
| 0.7 | 9.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.7 | 2.1 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.7 | 2.1 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.7 | 4.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.7 | 2.1 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.7 | 4.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.7 | 2.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.7 | 2.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.7 | 3.4 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.7 | 2.0 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.7 | 2.7 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.7 | 4.7 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.7 | 6.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.7 | 8.7 | GO:0060789 | hair follicle placode formation(GO:0060789) |
| 0.7 | 8.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.7 | 2.7 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.7 | 0.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.7 | 0.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.7 | 1.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.7 | 2.6 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.7 | 2.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.7 | 9.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.7 | 3.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.7 | 2.0 | GO:2000340 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.7 | 5.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.7 | 2.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.7 | 2.0 | GO:0070377 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.7 | 2.6 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.7 | 4.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.6 | 2.6 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.6 | 1.3 | GO:2000192 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of fatty acid transport(GO:2000192) |
| 0.6 | 6.4 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.6 | 2.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.6 | 2.6 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.6 | 3.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.6 | 5.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 | 8.3 | GO:0060613 | fat pad development(GO:0060613) |
| 0.6 | 5.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.6 | 5.1 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.6 | 0.6 | GO:0060932 | His-Purkinje system cell differentiation(GO:0060932) |
| 0.6 | 1.9 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.6 | 3.1 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.6 | 1.9 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.6 | 4.4 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.6 | 3.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.6 | 3.1 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.6 | 3.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.6 | 2.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.6 | 1.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.6 | 10.4 | GO:0015871 | choline transport(GO:0015871) |
| 0.6 | 1.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.6 | 2.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.6 | 1.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.6 | 0.6 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.6 | 1.8 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.6 | 4.8 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.6 | 0.6 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.6 | 2.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.6 | 1.8 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.6 | 2.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.6 | 6.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.6 | 0.6 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
| 0.6 | 3.0 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.6 | 3.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.6 | 5.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.6 | 1.8 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.6 | 4.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.6 | 1.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.6 | 1.8 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.6 | 2.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.6 | 1.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.6 | 3.0 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.6 | 1.8 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.6 | 2.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.6 | 1.2 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.6 | 5.3 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.6 | 1.8 | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
| 0.6 | 7.0 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.6 | 4.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.6 | 2.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.6 | 2.3 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.6 | 3.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.6 | 2.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.6 | 2.9 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.6 | 2.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.6 | 4.6 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.6 | 1.2 | GO:0060594 | mammary gland specification(GO:0060594) |
| 0.6 | 1.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.6 | 4.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.6 | 2.9 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.6 | 1.7 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.6 | 0.6 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.6 | 2.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.6 | 0.6 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.6 | 0.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.6 | 2.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.6 | 2.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.6 | 0.6 | GO:0090132 | epithelium migration(GO:0090132) |
| 0.6 | 3.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 | 2.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.6 | 3.3 | GO:0010814 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.6 | 2.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.6 | 0.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.6 | 3.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.6 | 3.3 | GO:0030047 | actin modification(GO:0030047) |
| 0.6 | 14.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.5 | 2.2 | GO:0097435 | fibril organization(GO:0097435) |
| 0.5 | 11.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.5 | 1.6 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.5 | 1.6 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.5 | 2.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.5 | 4.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.5 | 2.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.5 | 5.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.5 | 1.6 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.5 | 7.0 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.5 | 16.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.5 | 1.1 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.5 | 2.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.5 | 3.8 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.5 | 2.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.5 | 1.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 | 1.1 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.5 | 2.1 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.5 | 1.1 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.5 | 1.6 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.5 | 3.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.5 | 2.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.5 | 5.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.5 | 0.5 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.5 | 2.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.5 | 2.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.5 | 5.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 | 0.5 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.5 | 4.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.5 | 3.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.5 | 5.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.5 | 13.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.5 | 3.6 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.5 | 1.5 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.5 | 0.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.5 | 2.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.5 | 1.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.5 | 4.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.5 | 6.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 1.5 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.5 | 3.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.5 | 3.5 | GO:0015791 | polyol transport(GO:0015791) myo-inositol transport(GO:0015798) |
| 0.5 | 5.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.5 | 5.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.5 | 3.0 | GO:0042335 | cuticle development(GO:0042335) |
| 0.5 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 0.5 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.5 | 0.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.5 | 3.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 | 2.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.5 | 1.0 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.5 | 0.5 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.5 | 2.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.5 | 2.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.5 | 3.0 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.5 | 3.0 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.5 | 1.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.5 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.5 | 1.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.5 | 2.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.5 | 1.0 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.5 | 1.5 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.5 | 3.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.5 | 9.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.5 | 1.0 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.5 | 1.0 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.5 | 2.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.5 | 5.4 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.5 | 1.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.5 | 1.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.5 | 6.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.5 | 1.5 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.5 | 1.0 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.5 | 1.5 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.5 | 10.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.5 | 0.5 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.5 | 1.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.5 | 1.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.5 | 2.4 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
| 0.5 | 4.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.5 | 6.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.5 | 2.9 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.5 | 23.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.5 | 3.3 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.5 | 1.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 | 1.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.5 | 1.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.5 | 3.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 | 2.4 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.5 | 1.9 | GO:1902304 | phosphatidylserine exposure on blood platelet(GO:0097045) positive regulation of potassium ion export(GO:1902304) |
| 0.5 | 1.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.5 | 1.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 | 3.8 | GO:0030578 | PML body organization(GO:0030578) |
| 0.5 | 0.9 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.5 | 1.4 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.5 | 2.3 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.5 | 1.9 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.5 | 2.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.5 | 3.7 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.5 | 2.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.5 | 2.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.5 | 1.9 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.5 | 2.3 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.5 | 2.3 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.5 | 2.8 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.5 | 1.4 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.5 | 2.8 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.5 | 0.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.5 | 3.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.5 | 0.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.5 | 1.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.5 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.5 | 2.3 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
| 0.5 | 4.6 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.5 | 2.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.5 | 11.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.5 | 1.8 | GO:0045401 | response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) beta selection(GO:0043366) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
| 0.5 | 2.3 | GO:0032796 | uropod organization(GO:0032796) |
| 0.5 | 2.8 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.5 | 2.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.5 | 1.8 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.5 | 0.9 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.5 | 2.3 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.5 | 7.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.5 | 5.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.5 | 5.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.5 | 1.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.5 | 2.3 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.5 | 0.5 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.5 | 3.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.5 | 1.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.5 | 9.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.4 | 3.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.4 | 0.4 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.4 | 3.6 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.4 | 4.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.4 | 1.3 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.4 | 1.3 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
| 0.4 | 1.3 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.4 | 2.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.4 | 1.8 | GO:0048378 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.4 | 2.7 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
| 0.4 | 8.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.4 | 1.3 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.4 | 3.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.4 | 2.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.4 | 1.3 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.4 | 4.8 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.4 | 5.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 | 1.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.4 | 11.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.4 | 0.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.4 | 0.9 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
| 0.4 | 0.4 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
| 0.4 | 7.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 | 2.6 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 | 1.3 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.4 | 1.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.4 | 0.9 | GO:1900390 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.4 | 1.3 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.4 | 3.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.4 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 | 1.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.4 | 1.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 3.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.4 | 1.3 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.4 | 3.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.4 | 1.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.4 | 6.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.4 | 0.9 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.4 | 1.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.4 | 0.9 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.4 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.4 | 0.4 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.4 | 2.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 | 3.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.4 | 3.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.4 | 1.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.4 | 1.3 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.4 | 1.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.4 | 1.7 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.4 | 3.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.4 | 1.3 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.4 | 0.4 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
| 0.4 | 3.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 | 2.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 | 0.8 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.4 | 7.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.4 | 7.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 | 4.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.4 | 1.2 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.4 | 0.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
| 0.4 | 0.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.4 | 2.5 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.4 | 0.8 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 0.4 | 1.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 4.1 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 0.4 | 2.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.4 | 2.1 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.4 | 0.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.4 | 0.8 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.4 | 2.1 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.4 | 7.8 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.4 | 3.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 | 2.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.4 | 1.2 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.4 | 0.4 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.4 | 3.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.4 | 3.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.4 | 0.8 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 0.4 | 2.0 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 | 1.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.4 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.4 | 2.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.4 | 5.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.4 | 4.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.4 | 12.5 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.4 | 2.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.4 | 8.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.4 | 2.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 0.4 | 5.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.4 | 1.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 | 4.0 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 0.4 | 0.8 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.4 | 1.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 | 2.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.4 | 2.4 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 | 0.8 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.4 | 2.8 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.4 | 2.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 | 2.0 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.4 | 3.9 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.4 | 3.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.4 | 1.2 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 0.4 | 3.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.4 | 2.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.4 | 1.6 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.4 | 1.2 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.4 | 3.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.4 | 0.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.4 | 3.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 | 2.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.4 | 6.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.4 | 3.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.4 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 | 1.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.4 | 1.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.4 | 1.2 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.4 | 7.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.4 | 1.5 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) |
| 0.4 | 0.8 | GO:0048597 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.4 | 0.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.4 | 3.8 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.4 | 2.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.4 | 5.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.4 | 3.4 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 0.4 | 0.8 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.4 | 0.8 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.4 | 1.1 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.4 | 3.0 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.4 | 2.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.4 | 2.7 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
| 0.4 | 0.8 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.4 | 1.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.4 | 2.6 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.4 | 0.4 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.4 | 1.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.4 | 1.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 | 3.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.4 | 1.1 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.4 | 2.6 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.4 | 3.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 | 0.4 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 0.4 | 1.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.4 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.4 | 1.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.4 | 1.1 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
| 0.4 | 2.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.4 | 0.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.4 | 0.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.4 | 3.7 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 0.4 | 0.4 | GO:0044208 | AMP biosynthetic process(GO:0006167) 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 1.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.4 | 5.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.4 | 2.6 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.4 | 4.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.4 | 1.1 | GO:2000855 | renin-angiotensin regulation of aldosterone production(GO:0002018) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.4 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
| 0.4 | 2.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.4 | 13.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.4 | 1.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.4 | 1.1 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.4 | 0.7 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.4 | 1.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.4 | 0.7 | GO:0015817 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.4 | 1.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.4 | 1.1 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.4 | 0.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.4 | 1.1 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.4 | 5.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.4 | 2.9 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.4 | 2.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.4 | 4.3 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.4 | 5.0 | GO:0015747 | urate transport(GO:0015747) |
| 0.4 | 2.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 | 0.7 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.4 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.4 | 4.7 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.4 | 1.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.4 | 0.4 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.4 | 2.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.4 | 1.1 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.4 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.4 | 2.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 1.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.4 | 5.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.4 | 1.4 | GO:0043542 | endothelial cell migration(GO:0043542) |
| 0.4 | 13.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.4 | 3.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.4 | 0.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.4 | 1.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.4 | 3.2 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.4 | 2.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 | 1.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.3 | 3.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.3 | 0.3 | GO:0060525 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.3 | 3.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.3 | 2.4 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.3 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 0.3 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.3 | 1.0 | GO:0034205 | beta-amyloid formation(GO:0034205) |
| 0.3 | 1.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.3 | 1.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 | 2.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 | 1.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.3 | 0.7 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.3 | 1.0 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.3 | 1.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 | 5.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.3 | 4.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.3 | 6.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.3 | 8.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.3 | 2.4 | GO:0060356 | leucine import(GO:0060356) |
| 0.3 | 2.0 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.3 | 1.4 | GO:0019673 | GDP-mannose biosynthetic process(GO:0009298) GDP-mannose metabolic process(GO:0019673) |
| 0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.3 | 3.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.3 | 2.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.3 | 0.3 | GO:0010043 | response to zinc ion(GO:0010043) |
| 0.3 | 1.4 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.3 | 5.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.3 | 2.4 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.3 | 0.3 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.3 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.3 | 2.4 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.3 | 1.0 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.3 | 2.0 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.3 | 0.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.3 | 5.7 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 0.3 | 4.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.3 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.3 | 2.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.3 | 0.7 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.3 | 4.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.3 | 3.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 | 6.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.3 | 2.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.3 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.3 | 1.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.3 | 1.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.3 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 | 3.6 | GO:0015886 | heme transport(GO:0015886) |
| 0.3 | 1.0 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.3 | 2.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.3 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.3 | 4.6 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.3 | 1.6 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.3 | 5.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 1.3 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.3 | 1.0 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.3 | 1.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 | 4.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.3 | 1.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.3 | 0.6 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.3 | 2.3 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.3 | 0.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 2.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.3 | 7.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.3 | 0.3 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.3 | 3.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 | 1.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.3 | 0.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.3 | 3.5 | GO:0060065 | uterus development(GO:0060065) |
| 0.3 | 1.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 | 1.6 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.3 | 1.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 | 4.2 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.3 | 2.2 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.3 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.3 | 2.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.3 | 0.6 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.3 | 3.2 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.3 | 1.0 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.3 | 1.0 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.3 | 0.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 | 1.0 | GO:0030222 | eosinophil differentiation(GO:0030222) regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.3 | 5.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.3 | 4.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.3 | 9.1 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.3 | 2.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.3 | 0.9 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.3 | 2.5 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.3 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.3 | 1.9 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.3 | 1.9 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 | 1.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 | 3.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.3 | 0.9 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.3 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.3 | 2.5 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.3 | 3.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 | 0.9 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.3 | 0.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.3 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.3 | 1.2 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.3 | 1.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.3 | 0.9 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.3 | 4.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.3 | 0.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.3 | 0.6 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.3 | 9.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.3 | 1.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.3 | 3.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.3 | 2.7 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.3 | 3.0 | GO:0010255 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.3 | 0.9 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.3 | 1.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.3 | 9.0 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.3 | 4.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.3 | 1.2 | GO:0036294 | cellular response to decreased oxygen levels(GO:0036294) |
| 0.3 | 1.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.3 | 3.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.3 | 0.3 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.3 | 0.9 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.3 | 26.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.3 | 0.6 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.3 | 4.2 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.3 | 6.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.3 | 2.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.3 | 6.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.3 | 0.9 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.3 | 1.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.3 | 1.5 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.3 | 3.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.3 | 1.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.3 | 1.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.3 | 0.9 | GO:0051300 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.3 | 2.9 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
| 0.3 | 3.5 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.3 | 0.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 0.3 | 1.5 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.3 | 0.9 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.3 | 1.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 | 5.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.3 | 0.9 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.3 | 5.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.3 | 0.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.3 | 3.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.3 | 3.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.3 | 1.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.3 | 3.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 | 1.4 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.3 | 0.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.3 | 1.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.3 | 0.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.3 | 1.4 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.3 | 0.9 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.3 | 2.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.3 | 1.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.3 | 1.7 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.3 | 1.7 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 | 6.8 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.3 | 0.3 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.3 | 1.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 0.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.3 | 3.7 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 | 3.7 | GO:0007379 | segment specification(GO:0007379) |
| 0.3 | 2.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.3 | 0.8 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.3 | 7.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 1.7 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.3 | 1.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.3 | 0.8 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.3 | 2.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.3 | 2.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.3 | 2.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 | 1.4 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.3 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.3 | 5.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.3 | 0.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.3 | 0.8 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.3 | 0.5 | GO:0070781 | response to biotin(GO:0070781) |
| 0.3 | 3.6 | GO:0015074 | DNA integration(GO:0015074) |
| 0.3 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
| 0.3 | 1.6 | GO:0032439 | endosome localization(GO:0032439) |
| 0.3 | 1.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.3 | 1.4 | GO:0045007 | depurination(GO:0045007) |
| 0.3 | 1.6 | GO:2000504 | negative regulation of Fas signaling pathway(GO:1902045) positive regulation of blood vessel remodeling(GO:2000504) |
| 0.3 | 0.5 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.3 | 1.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 | 0.3 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.3 | 2.4 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.3 | 0.5 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.3 | 1.1 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.3 | 1.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 | 0.8 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.3 | 1.3 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 | 0.5 | GO:0015827 | tryptophan transport(GO:0015827) |
| 0.3 | 1.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.3 | 0.8 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.3 | 0.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.3 | 0.8 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.3 | 3.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 2.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 | 1.1 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.3 | 1.1 | GO:0048696 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.3 | 0.5 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.3 | 4.0 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
| 0.3 | 2.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.3 | 0.5 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.3 | 7.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 1.3 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.3 | 3.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 1.6 | GO:0051923 | sulfation(GO:0051923) |
| 0.3 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.3 | 0.5 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.3 | 0.5 | GO:0090244 | external genitalia morphogenesis(GO:0035261) Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.3 | 2.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.3 | 0.3 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 | 0.5 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.3 | 0.3 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.3 | 0.8 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.3 | 6.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.3 | 0.5 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.3 | 16.6 | GO:0043297 | apical junction assembly(GO:0043297) |
| 0.3 | 1.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.3 | 6.0 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.3 | 3.1 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.3 | 1.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.3 | 1.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.3 | 1.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.3 | 1.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 1.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.3 | 2.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.3 | 1.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.3 | 0.8 | GO:1990785 | initiation of primordial ovarian follicle growth(GO:0001544) response to water-immersion restraint stress(GO:1990785) |
| 0.3 | 7.6 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.3 | 0.8 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.3 | 0.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.3 | 0.8 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.3 | 2.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 | 0.8 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.3 | 1.8 | GO:0019400 | alditol metabolic process(GO:0019400) |
| 0.3 | 0.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.3 | 2.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.3 | 1.0 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.3 | 0.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.3 | 0.5 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.3 | 0.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
| 0.3 | 0.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.2 | 1.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.2 | 0.7 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.2 | 1.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 | 3.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 0.7 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 1.5 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.2 | 2.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.2 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 1.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 2.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 | 0.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.2 | 6.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.2 | 3.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.2 | 1.0 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 3.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.2 | 0.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.2 | 0.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 4.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.2 | 1.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.2 | 2.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.2 | 2.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 0.2 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 0.2 | 3.1 | GO:0080111 | DNA demethylation(GO:0080111) |
| 0.2 | 1.2 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 | 0.5 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.2 | 3.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.2 | 0.5 | GO:1904044 | response to aldosterone(GO:1904044) |
| 0.2 | 0.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.2 | 0.7 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
| 0.2 | 0.7 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.2 | 0.5 | GO:0036065 | fucosylation(GO:0036065) |
| 0.2 | 3.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 1.2 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 | 0.2 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 1.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 0.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
| 0.2 | 6.5 | GO:0015893 | drug transport(GO:0015893) |
| 0.2 | 1.0 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.2 | 3.1 | GO:0046697 | decidualization(GO:0046697) |
| 0.2 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.2 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 | 2.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
| 0.2 | 0.5 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.2 | 3.8 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.2 | 0.2 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
| 0.2 | 9.5 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.2 | 0.7 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.2 | 0.9 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 0.2 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.2 | 1.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.2 | 0.9 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 | 1.2 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.2 | 1.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.2 | 8.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
| 0.2 | 2.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.2 | 1.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 | 0.2 | GO:0072175 | embryonic epithelial tube formation(GO:0001838) epithelial tube formation(GO:0072175) |
| 0.2 | 0.7 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.2 | 1.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.2 | 5.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 | 0.9 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 2.1 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.2 | 0.7 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.2 | 1.1 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.2 | 2.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.2 | 0.7 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.2 | 0.9 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.2 | 0.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 | 0.7 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
| 0.2 | 6.1 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.2 | 0.7 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 | 4.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.2 | 0.5 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.2 | 1.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.2 | 0.5 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
| 0.2 | 1.6 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 2.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.2 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 1.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 0.7 | GO:0001890 | placenta development(GO:0001890) |
| 0.2 | 1.1 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 1.6 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.2 | 0.7 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.2 | 2.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 1.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.2 | 2.0 | GO:0097205 | renal filtration(GO:0097205) |
| 0.2 | 2.0 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.2 | 0.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.2 | 0.9 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 | 0.2 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.2 | 0.7 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.2 | 1.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.2 | 13.0 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.2 | 1.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.2 | 2.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 | 2.0 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.2 | 2.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 2.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.2 | 0.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.2 | 5.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.2 | 1.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.2 | 0.9 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.2 | 1.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.2 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.2 | 7.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.2 | 1.9 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
| 0.2 | 0.2 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.2 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.2 | 1.7 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 | 1.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.2 | 1.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.2 | 0.2 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.2 | 0.8 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.2 | 4.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.2 | 1.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 0.8 | GO:0036344 | platelet morphogenesis(GO:0036344) |
| 0.2 | 0.8 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.2 | 2.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.2 | 2.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.2 | 1.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 | 1.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.2 | 0.8 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.2 | 1.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.2 | 1.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.2 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.2 | 3.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.2 | 8.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.2 | 0.8 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 | 4.6 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
| 0.2 | 3.1 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 0.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.2 | 0.8 | GO:0016137 | glycoside metabolic process(GO:0016137) |
| 0.2 | 0.2 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.2 | 4.9 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
| 0.2 | 1.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 0.2 | 3.9 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.2 | 1.4 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 0.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
| 0.2 | 0.6 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.2 | 1.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 | 1.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.2 | 0.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.2 | 3.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.2 | 3.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 | 1.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 0.6 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.2 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 0.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 4.0 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
| 0.2 | 0.2 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 | 0.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 | 0.2 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.2 | 0.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.2 | 0.2 | GO:0030041 | actin filament polymerization(GO:0030041) |
| 0.2 | 3.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.2 | 0.8 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 | 3.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.2 | 16.2 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 0.6 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 | 8.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.2 | 0.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.2 | 0.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 1.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.2 | 1.6 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
| 0.2 | 1.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.2 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 | 0.6 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 | 1.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.2 | 1.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 1.2 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 | 3.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.2 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.2 | 1.5 | GO:0007350 | blastoderm segmentation(GO:0007350) |
| 0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.2 | 0.2 | GO:0043491 | protein kinase B signaling(GO:0043491) |
| 0.2 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.2 | 6.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.2 | 1.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.2 | 3.3 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.2 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.2 | 3.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.2 | 0.8 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 1.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.2 | 1.5 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.2 | 0.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 | 1.9 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.2 | 0.8 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.2 | 0.6 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.2 | 0.8 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 | 2.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 | 1.9 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.2 | 1.3 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.2 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 | 0.8 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
| 0.2 | 0.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.2 | 28.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 | 0.6 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 | 1.3 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.2 | 1.1 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) |
| 0.2 | 2.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 0.8 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 | 0.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.2 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 | 0.6 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.2 | 6.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 0.4 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.2 | 1.1 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.2 | 2.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 0.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.2 | 2.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.2 | 5.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.2 | 0.2 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.2 | 1.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.2 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 0.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.2 | 2.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 | 1.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.2 | 0.6 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.2 | 1.8 | GO:0030238 | male sex determination(GO:0030238) |
| 0.2 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
| 0.2 | 2.9 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.2 | 0.4 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.2 | 0.9 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 | 3.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.2 | 4.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.2 | 0.9 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 | 0.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.2 | 2.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.2 | 3.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 | 0.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 | 1.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 | 1.3 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.2 | 2.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 | 0.7 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 | 0.4 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.2 | 2.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 3.4 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.2 | 0.7 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 3.2 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.2 | 0.7 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.2 | 0.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 | 0.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.2 | 3.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.2 | 3.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 | 1.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.2 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 2.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 | 0.2 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
| 0.2 | 3.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.2 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.2 | 0.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.2 | 1.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.2 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.2 | 0.4 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.2 | 2.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.2 | 1.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.2 | 3.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.2 | 1.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.2 | 1.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.2 | 0.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 | 1.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.2 | 0.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.2 | 0.9 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 | 1.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.2 | 3.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 15.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.2 | 0.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 1.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.2 | 1.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.2 | 0.5 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 | 12.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 | 0.3 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
| 0.2 | 2.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 | 4.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 0.3 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 | 0.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 | 1.0 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 | 0.2 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
| 0.2 | 0.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.2 | 0.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
| 0.2 | 2.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.2 | 0.3 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 | 0.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 3.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 | 2.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.2 | 2.6 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.2 | 0.2 | GO:0001974 | blood vessel remodeling(GO:0001974) |
| 0.2 | 0.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.2 | 2.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 0.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.2 | 3.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
| 0.2 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 0.8 | GO:0051095 | regulation of helicase activity(GO:0051095) |
| 0.2 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.2 | 0.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.2 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 | 4.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.2 | 1.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 | 0.7 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.2 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.2 | 0.2 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
| 0.2 | 0.5 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.2 | 0.5 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.2 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.2 | 1.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 | 0.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.2 | 1.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 | 1.9 | GO:0007431 | salivary gland development(GO:0007431) |
| 0.2 | 0.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.2 | 2.3 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.2 | 3.9 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.2 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.2 | 0.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 2.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.2 | 3.0 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.2 | 1.9 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.2 | 0.5 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.2 | 10.4 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.2 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.2 | 6.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.2 | 0.2 | GO:0048819 | hair cycle phase(GO:0044851) regulation of hair follicle maturation(GO:0048819) |
| 0.2 | 0.2 | GO:0001763 | morphogenesis of a branching structure(GO:0001763) |
| 0.2 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 | 10.1 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.2 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.2 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.2 | 0.2 | GO:0001878 | response to yeast(GO:0001878) |
| 0.2 | 18.9 | GO:0070268 | cornification(GO:0070268) |
| 0.2 | 10.8 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.2 | 1.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.2 | 0.6 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 | 0.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.2 | 0.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.2 | 0.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.2 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 0.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 | 0.5 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.2 | 0.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 0.2 | 10.1 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.2 | 1.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.2 | 0.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.2 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.2 | 0.6 | GO:0032892 | positive regulation of organic acid transport(GO:0032892) |
| 0.2 | 1.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.2 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 0.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 | 4.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 | 3.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 | 0.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 1.2 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.1 | 0.3 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.1 | 0.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 12.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 1.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 3.9 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
| 0.1 | 16.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.9 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 1.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 2.4 | GO:0045191 | regulation of isotype switching(GO:0045191) |
| 0.1 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 1.0 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 1.3 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 | 0.6 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.1 | 0.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 0.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
| 0.1 | 0.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 0.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 | 2.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 0.6 | GO:0070231 | T cell apoptotic process(GO:0070231) |
| 0.1 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 1.3 | GO:0010586 | miRNA metabolic process(GO:0010586) |
| 0.1 | 0.4 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.7 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.1 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.4 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
| 0.1 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 0.4 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
| 0.1 | 0.4 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 1.8 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
| 0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 0.3 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 | 1.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.6 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.8 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.1 | 2.0 | GO:0032963 | collagen metabolic process(GO:0032963) |
| 0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 | 0.4 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 | 1.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.1 | 4.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.1 | 1.0 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 1.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 6.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.3 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.1 | 2.8 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.1 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 | 1.2 | GO:0043586 | tongue development(GO:0043586) |
| 0.1 | 0.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.1 | 3.2 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
| 0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 3.3 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 0.1 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.5 | GO:0018277 | protein deamination(GO:0018277) |
| 0.1 | 0.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.1 | 0.7 | GO:0007549 | dosage compensation(GO:0007549) |
| 0.1 | 0.9 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.1 | 6.7 | GO:0098754 | detoxification(GO:0098754) |
| 0.1 | 1.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 1.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.1 | 2.0 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.7 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.1 | 5.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 1.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 0.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 | 0.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 | 0.6 | GO:0030879 | mammary gland development(GO:0030879) |
| 0.1 | 5.3 | GO:0045682 | regulation of epidermis development(GO:0045682) |
| 0.1 | 0.9 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.1 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.1 | 0.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 2.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.4 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 | 1.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 0.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 0.5 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.1 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.1 | 1.8 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.1 | 0.9 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 7.6 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 3.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.1 | 0.6 | GO:0060348 | bone development(GO:0060348) |
| 0.1 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.1 | 0.2 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.1 | 0.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 3.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 | 0.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 1.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.1 | 1.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 2.5 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 3.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.4 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 | 0.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 | 2.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
| 0.1 | 0.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.1 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.1 | 0.9 | GO:1903507 | negative regulation of nucleic acid-templated transcription(GO:1903507) |
| 0.1 | 2.7 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 0.4 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 1.0 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.1 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 1.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 0.4 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.1 | 0.8 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.1 | 5.1 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
| 0.1 | 0.6 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 | 1.0 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.1 | 1.9 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 0.8 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 6.0 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 | 0.8 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.1 | 0.7 | GO:0017144 | drug metabolic process(GO:0017144) |
| 0.1 | 9.3 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.1 | 1.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 2.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 0.1 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
| 0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.1 | 1.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 | 2.1 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
| 0.1 | 0.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.5 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
| 0.1 | 1.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 1.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.1 | 1.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.1 | 0.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.1 | 0.1 | GO:0035148 | tube formation(GO:0035148) |
| 0.1 | 0.3 | GO:0070293 | renal absorption(GO:0070293) |
| 0.1 | 0.1 | GO:0006771 | riboflavin metabolic process(GO:0006771) |
| 0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 | 0.7 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.1 | 1.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
| 0.1 | 0.3 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.1 | 1.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.1 | 1.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 0.3 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 | 2.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 | 6.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 0.8 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.3 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.1 | 2.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 | 1.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.1 | 0.4 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
| 0.1 | 2.0 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.1 | 0.2 | GO:0048793 | pronephros development(GO:0048793) |
| 0.1 | 0.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.1 | 3.6 | GO:0019395 | fatty acid oxidation(GO:0019395) |
| 0.1 | 2.4 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.1 | 1.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 1.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 7.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.1 | 0.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.1 | 1.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 | 0.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 | 0.3 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.1 | 0.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 | 3.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 6.7 | GO:0051607 | defense response to virus(GO:0051607) |
| 0.1 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.1 | 1.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.1 | GO:0055093 | response to hyperoxia(GO:0055093) |
| 0.1 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 0.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.5 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.1 | 1.0 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
| 0.1 | 0.2 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 0.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 | 0.4 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.1 | 8.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 0.6 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 0.2 | GO:0050777 | negative regulation of immune response(GO:0050777) |
| 0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.6 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 0.4 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.1 | 0.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 3.0 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
| 0.1 | 1.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 | 1.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 | 0.2 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
| 0.1 | 4.0 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 1.4 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.1 | 0.1 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
| 0.1 | 0.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 1.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 42.4 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.7 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.1 | 0.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 0.6 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
| 0.1 | 0.2 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
| 0.1 | 0.1 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.1 | 0.8 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.1 | 0.5 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 1.3 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.1 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 1.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 | 1.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.1 | 0.7 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 0.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 0.6 | GO:0051604 | protein maturation(GO:0051604) |
| 0.1 | 1.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 | 0.2 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.1 | 0.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 9.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.1 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.9 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.1 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 1.4 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.1 | 0.8 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.1 | 0.6 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
| 0.1 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 3.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 5.0 | GO:0050818 | regulation of coagulation(GO:0050818) |
| 0.1 | 1.0 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 5.7 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 1.4 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.1 | 0.9 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.2 | GO:1902275 | regulation of chromatin organization(GO:1902275) |
| 0.1 | 0.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 0.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 | 0.2 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.1 | 0.3 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.1 | 3.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
| 0.1 | 0.5 | GO:0051099 | positive regulation of binding(GO:0051099) |
| 0.1 | 0.9 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 | 0.6 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.1 | 0.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
| 0.1 | 0.4 | GO:0019081 | viral translation(GO:0019081) |
| 0.1 | 0.4 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.1 | 0.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 2.3 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
| 0.1 | 0.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 2.2 | GO:0090175 | regulation of establishment of planar polarity(GO:0090175) |
| 0.1 | 0.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
| 0.1 | 0.4 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.1 | 1.2 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 0.1 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.1 | 0.3 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
| 0.1 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.1 | 2.3 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.1 | 1.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.1 | 1.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 1.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 | 0.8 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.1 | 0.7 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.1 | 2.0 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.1 | 2.0 | GO:0001822 | kidney development(GO:0001822) |
| 0.1 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.5 | GO:0061470 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
| 0.1 | 0.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.1 | 0.6 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 0.1 | GO:0002697 | regulation of immune effector process(GO:0002697) |
| 0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.1 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 1.0 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.6 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.1 | 1.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 0.5 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
| 0.1 | 0.5 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
| 0.1 | 0.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 | 0.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
| 0.1 | 1.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 0.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 | 0.2 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.1 | 5.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.1 | 0.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 0.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.1 | GO:0018126 | protein hydroxylation(GO:0018126) |
| 0.1 | 0.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 0.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.1 | 0.4 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.1 | 0.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 1.9 | GO:0007584 | response to nutrient(GO:0007584) |
| 0.1 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 0.1 | 4.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 1.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.6 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 1.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 0.1 | 0.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 1.8 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 | 0.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 0.2 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.1 | 0.1 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
| 0.1 | 0.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 0.4 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 2.6 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.2 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation by host of symbiont transcription(GO:0052472) |
| 0.1 | 0.1 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090100) |
| 0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 1.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.1 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
| 0.1 | 1.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 | 6.5 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.1 | 0.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.1 | 1.0 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
| 0.1 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 1.0 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 | 0.5 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.1 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 2.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.1 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.1 | 0.5 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 0.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 0.1 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 1.0 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.1 | 4.2 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.1 | 0.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 | 0.7 | GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway(GO:0033143) |
| 0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
| 0.1 | 0.1 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.2 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.1 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 | 1.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 | 0.1 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
| 0.1 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 | 3.4 | GO:0010324 | membrane invagination(GO:0010324) |
| 0.1 | 0.5 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
| 0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
| 0.1 | 0.4 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 | 1.1 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 | 2.8 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 0.7 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
| 0.1 | 0.1 | GO:0035606 | killing by symbiont of host cells(GO:0001907) peptidyl-cysteine S-trans-nitrosylation(GO:0035606) disruption by symbiont of host cell(GO:0044004) |
| 0.1 | 0.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 | 0.4 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 0.2 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.1 | 1.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.1 | 3.9 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.1 | 2.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.8 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.1 | GO:1904888 | cranial skeletal system development(GO:1904888) |
| 0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 1.2 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 0.2 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.1 | 1.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 | 1.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.1 | 0.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
| 0.1 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 0.1 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 | 1.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.3 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
| 0.1 | 0.2 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 0.1 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
| 0.1 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 2.7 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
| 0.1 | 0.2 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
| 0.1 | 0.1 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
| 0.1 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.1 | 1.5 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.1 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 | 0.2 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 | 0.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.1 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.0 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 0.5 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 | 1.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 | 1.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 0.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 | 0.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 0.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.0 | 0.6 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.0 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.0 | 0.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.0 | 0.1 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.0 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
| 0.0 | 0.4 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.0 | 4.1 | GO:0032259 | methylation(GO:0032259) |
| 0.0 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 0.4 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.0 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.0 | 1.3 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.0 | 0.9 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.0 | 0.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.0 | 1.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 0.2 | GO:0071315 | negative regulation of Wnt protein secretion(GO:0061358) cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.0 | 0.4 | GO:1902236 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.0 | 0.4 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.0 | 0.1 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 | 0.0 | GO:0042107 | cytokine metabolic process(GO:0042107) |
| 0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.0 | 0.1 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.0 | 0.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.0 | 0.3 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.9 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.0 | 0.2 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 | 0.3 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 0.0 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 | 0.3 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
| 0.0 | 2.3 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.0 | 0.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
| 0.0 | 0.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 1.6 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
| 0.0 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.0 | 0.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 0.4 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.0 | 0.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
| 0.0 | 0.8 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 | 1.6 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 | 0.6 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
| 0.0 | 0.5 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.0 | 0.6 | GO:0034111 | negative regulation of homotypic cell-cell adhesion(GO:0034111) |
| 0.0 | 0.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.0 | 0.2 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
| 0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.0 | 0.2 | GO:0090398 | cellular senescence(GO:0090398) |
| 0.0 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.0 | 0.4 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 | 0.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.0 | 16.8 | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter(GO:0000122) |
| 0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.0 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 0.1 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
| 0.0 | 0.1 | GO:0046514 | ceramide catabolic process(GO:0046514) |
| 0.0 | 3.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.0 | 0.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 | 0.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 | 0.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
| 0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.2 | GO:0010171 | body morphogenesis(GO:0010171) |
| 0.0 | 0.1 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.0 | 0.0 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.0 | 0.0 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.0 | 0.2 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.0 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 | 0.1 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.0 | 0.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
| 0.0 | 0.4 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.0 | 0.5 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.0 | 0.6 | GO:0031214 | biomineral tissue development(GO:0031214) |
| 0.0 | 0.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
| 0.0 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.0 | 0.0 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
| 0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.0 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 0.0 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
| 0.0 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 | 1.6 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.0 | 0.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 | 0.0 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.0 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 0.2 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
| 0.0 | 0.0 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.0 | 0.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 | 0.1 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 | 0.1 | GO:0097659 | nucleic acid-templated transcription(GO:0097659) |
| 0.0 | 0.2 | GO:0043473 | pigmentation(GO:0043473) |
| 0.0 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 | 0.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.1 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
| 0.0 | 0.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 0.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.0 | 1.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 | 0.0 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 0.0 | 0.7 | GO:0019751 | polyol metabolic process(GO:0019751) |
| 0.0 | 0.1 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 | 0.0 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.0 | 0.0 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 | 0.0 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 | 0.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 7.9 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 1.9 | 1.9 | GO:0031252 | cell leading edge(GO:0031252) |
| 1.9 | 7.7 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.4 | 4.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 1.3 | 6.7 | GO:0032449 | CBM complex(GO:0032449) |
| 1.3 | 3.9 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 1.1 | 5.6 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 1.1 | 3.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.1 | 5.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 1.0 | 3.1 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 1.0 | 41.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 1.0 | 11.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.9 | 4.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.9 | 0.9 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.9 | 1.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.9 | 2.7 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.8 | 3.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.8 | 5.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.8 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.8 | 1.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.8 | 2.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.8 | 6.2 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.8 | 10.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.8 | 2.3 | GO:0008623 | CHRAC(GO:0008623) |
| 0.7 | 3.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.7 | 11.0 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.7 | 2.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.7 | 3.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.7 | 5.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.7 | 2.9 | GO:0044753 | amphisome(GO:0044753) |
| 0.7 | 5.0 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.7 | 2.8 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.7 | 2.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.7 | 7.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.7 | 2.7 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.7 | 2.0 | GO:0042641 | actomyosin(GO:0042641) |
| 0.7 | 3.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.6 | 27.0 | GO:0030057 | desmosome(GO:0030057) |
| 0.6 | 2.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.6 | 2.5 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.6 | 2.5 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.6 | 1.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.6 | 3.1 | GO:0044393 | microspike(GO:0044393) |
| 0.6 | 3.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.6 | 4.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.6 | 3.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.6 | 13.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.6 | 4.5 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.6 | 3.4 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.6 | 3.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.5 | 7.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.5 | 5.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.5 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.5 | 2.6 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.5 | 1.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.5 | 6.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.5 | 1.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.5 | 5.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.5 | 2.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.5 | 5.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.5 | 5.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.5 | 5.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.5 | 1.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.5 | 3.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.5 | 2.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.5 | 1.8 | GO:0031523 | Myb complex(GO:0031523) |
| 0.4 | 2.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.4 | 1.3 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.4 | 1.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.4 | 1.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.4 | 2.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.4 | 2.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.4 | 1.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.4 | 1.7 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.4 | 0.9 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.4 | 3.4 | GO:0031415 | NatA complex(GO:0031415) |
| 0.4 | 1.7 | GO:0097196 | Shu complex(GO:0097196) |
| 0.4 | 0.9 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.4 | 3.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.4 | 2.5 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.4 | 2.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.4 | 2.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.4 | 3.4 | GO:0001740 | Barr body(GO:0001740) |
| 0.4 | 4.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.4 | 0.4 | GO:0009986 | cell surface(GO:0009986) |
| 0.4 | 9.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.4 | 3.3 | GO:0070695 | FHF complex(GO:0070695) |
| 0.4 | 0.8 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.4 | 3.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.4 | 5.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.4 | 2.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.4 | 40.1 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.4 | 2.0 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.4 | 3.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 1.9 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.4 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.4 | 2.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.4 | 1.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.4 | 2.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.4 | 11.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.4 | 0.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.4 | 3.4 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.4 | 2.2 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.4 | 2.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.4 | 39.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.4 | 0.4 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.4 | 3.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 1.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.4 | 8.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.4 | 3.2 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.4 | 6.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.4 | 2.5 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.4 | 1.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.4 | 1.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.4 | 14.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.4 | 9.8 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.4 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.3 | 3.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.3 | 3.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 2.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.3 | 2.7 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 0.3 | GO:0031253 | cell projection membrane(GO:0031253) |
| 0.3 | 7.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.3 | 5.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 3.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.3 | 1.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.3 | 1.3 | GO:0043204 | perikaryon(GO:0043204) |
| 0.3 | 6.9 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 2.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.3 | 69.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.3 | 2.6 | GO:0046930 | pore complex(GO:0046930) |
| 0.3 | 31.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.3 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.3 | 4.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 0.3 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.3 | 2.5 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.3 | 33.0 | GO:0005903 | brush border(GO:0005903) |
| 0.3 | 1.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.3 | 2.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.3 | 2.2 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.3 | 2.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 3.4 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 0.3 | 14.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 19.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.3 | 0.6 | GO:0043260 | laminin-3 complex(GO:0005608) laminin-11 complex(GO:0043260) |
| 0.3 | 10.8 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.3 | 0.9 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.3 | 2.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 3.0 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.3 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.3 | 1.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.3 | 0.9 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.3 | 0.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.3 | 6.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 4.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.3 | 2.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 29.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.3 | 1.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.3 | 2.0 | GO:0032009 | early phagosome(GO:0032009) |
| 0.3 | 2.5 | GO:0097413 | Lewy body(GO:0097413) |
| 0.3 | 2.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.3 | 6.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.3 | 4.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.3 | 30.6 | GO:0005811 | lipid particle(GO:0005811) |
| 0.3 | 0.6 | GO:0032059 | bleb(GO:0032059) |
| 0.3 | 2.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.3 | 1.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.3 | 3.8 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.3 | 4.1 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.3 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.3 | 1.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.3 | 2.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.3 | 1.6 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.3 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.3 | 0.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.3 | 2.9 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.3 | 0.8 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 0.8 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.3 | 1.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.3 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 1.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.3 | 12.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.3 | 6.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.3 | 2.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.3 | 2.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.3 | 3.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 0.7 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.2 | 4.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.2 | 8.5 | GO:0038201 | TOR complex(GO:0038201) |
| 0.2 | 2.5 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 3.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 1.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.2 | 4.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 7.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.2 | 0.5 | GO:1990462 | omegasome(GO:1990462) |
| 0.2 | 37.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.2 | 0.2 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.2 | 1.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 3.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.2 | 8.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 12.4 | GO:0032420 | stereocilium(GO:0032420) |
| 0.2 | 1.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
| 0.2 | 0.7 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.2 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 2.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 18.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.2 | 0.2 | GO:0005712 | chiasma(GO:0005712) |
| 0.2 | 0.5 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.2 | 1.1 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.2 | 1.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.2 | 1.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.2 | 2.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 1.8 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.2 | 0.7 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 4.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 0.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.2 | 2.0 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 5.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 16.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.2 | 1.7 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.2 | 1.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.2 | 3.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.2 | 3.4 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 22.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.2 | 6.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 6.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 4.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.2 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.2 | 4.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.2 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
| 0.2 | 3.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 870.4 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.2 | 15.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.2 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.2 | 1.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.2 | 0.6 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 0.2 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 3.0 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 1.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.2 | 2.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.2 | 35.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.2 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.2 | 1.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.2 | 0.8 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.2 | 0.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.2 | 1.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 1.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 0.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.2 | 1.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.2 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.2 | 0.6 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.2 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 0.4 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.2 | 4.5 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.2 | 0.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 3.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.2 | 0.6 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.2 | 2.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
| 0.2 | 0.7 | GO:0019867 | outer membrane(GO:0019867) |
| 0.2 | 4.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 0.5 | GO:0030689 | Noc complex(GO:0030689) |
| 0.2 | 2.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 0.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.2 | 5.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.2 | 1.2 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 2.4 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 2.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 0.5 | GO:0071159 | NF-kappaB p50/p65 complex(GO:0035525) NF-kappaB complex(GO:0071159) |
| 0.2 | 13.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.2 | 2.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 2.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 1.3 | GO:0000791 | euchromatin(GO:0000791) |
| 0.2 | 1.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.2 | 2.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.2 | 3.0 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 0.5 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.2 | 0.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.2 | 0.9 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.2 | 0.5 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.2 | 2.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 57.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.2 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 1.4 | GO:0005844 | polysome(GO:0005844) |
| 0.2 | 1.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) HULC complex(GO:0033503) |
| 0.2 | 0.5 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.2 | 0.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.2 | 1.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.1 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.1 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.1 | 1.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 62.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 1.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 1.3 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
| 0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 6.1 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 1.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.1 | 0.5 | GO:0036452 | ESCRT complex(GO:0036452) |
| 0.1 | 0.5 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.1 | 1.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 0.9 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 0.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 0.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.1 | 1.2 | GO:0044754 | autolysosome(GO:0044754) |
| 0.1 | 1.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 52.4 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 1.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 8.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 0.1 | 4.0 | GO:0005840 | ribosome(GO:0005840) |
| 0.1 | 0.6 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 6.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 2.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.1 | 2.3 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 0.5 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.1 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 1.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 5.9 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.1 | 0.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 3.5 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 5.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 31.1 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 4.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 22.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.1 | 1.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.1 | 2.2 | GO:0097346 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
| 0.1 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 0.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 11.2 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 3.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.1 | 0.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.1 | 0.1 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.1 | 40.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 5.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 6.8 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 14.6 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 1.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 1.9 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 2.5 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
| 0.1 | 1.1 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 0.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 1.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 1.0 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 1.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 3.0 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 2.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 2.8 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.1 | 1.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 2.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 2.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.1 | 1.6 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 3.6 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 4.6 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 1.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 0.8 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.1 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 1.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.1 | 2.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.1 | 26.9 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 16.6 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 2.0 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 2.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.7 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.1 | 1.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 0.3 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.1 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 7.8 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.1 | 1.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 0.2 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.1 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 6.0 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 1.6 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.1 | 0.2 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.1 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.1 | 0.2 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 0.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 2.6 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 2.4 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.1 | 0.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.1 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 4.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 2.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.1 | 0.2 | GO:0098857 | membrane microdomain(GO:0098857) |
| 0.1 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.1 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 2.8 | GO:0042581 | specific granule(GO:0042581) |
| 0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 3.5 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 155.6 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.0 | 0.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 1.1 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
| 0.0 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 3.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.0 | 0.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.0 | 1.4 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 1.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 2.5 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 1.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.0 | 1.1 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.8 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
| 0.0 | 0.5 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 7.4 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.3 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 1.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 8.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
| 0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.0 | 0.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 0.1 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.0 | 0.5 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.0 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 0.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.2 | GO:0055037 | recycling endosome(GO:0055037) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 7.9 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 1.8 | 5.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.7 | 5.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.7 | 5.2 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 1.7 | 6.9 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 1.7 | 5.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 1.7 | 10.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.7 | 6.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 1.6 | 14.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 1.5 | 10.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 1.5 | 4.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.4 | 18.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 1.4 | 5.6 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 1.4 | 4.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 1.4 | 4.1 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 1.3 | 7.9 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 1.3 | 6.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 1.3 | 6.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 1.3 | 7.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.2 | 3.7 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 1.2 | 5.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 1.2 | 3.6 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 1.2 | 4.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 1.2 | 5.9 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
| 1.2 | 3.5 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 1.2 | 10.5 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 1.2 | 7.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.1 | 3.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 1.1 | 2.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 1.1 | 5.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.1 | 3.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.1 | 3.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 1.1 | 1.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.0 | 24.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 1.0 | 3.1 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 1.0 | 3.1 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 1.0 | 5.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.0 | 5.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.0 | 4.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 1.0 | 9.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 1.0 | 7.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 1.0 | 3.0 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 1.0 | 7.0 | GO:0042806 | fucose binding(GO:0042806) |
| 1.0 | 9.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 1.0 | 2.9 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.0 | 2.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.0 | 5.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 1.0 | 2.9 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 1.0 | 2.9 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.9 | 2.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.9 | 7.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.9 | 5.6 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.9 | 2.8 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.9 | 7.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.9 | 2.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.9 | 2.8 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.9 | 2.7 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.9 | 4.5 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.9 | 0.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.9 | 2.7 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.9 | 2.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.9 | 2.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.9 | 4.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.9 | 5.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.9 | 4.3 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.9 | 2.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.9 | 4.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.8 | 3.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.8 | 5.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.8 | 4.2 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.8 | 5.8 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.8 | 4.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.8 | 4.9 | GO:0070905 | serine binding(GO:0070905) |
| 0.8 | 4.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.8 | 5.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.8 | 7.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.8 | 4.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.8 | 2.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.8 | 8.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.8 | 3.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.8 | 3.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.8 | 10.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.8 | 3.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.8 | 2.3 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.8 | 3.1 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.8 | 2.3 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.8 | 6.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.8 | 8.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.8 | 3.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.8 | 2.3 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.7 | 5.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.7 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
| 0.7 | 3.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.7 | 2.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.7 | 2.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.7 | 5.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.7 | 2.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.7 | 2.9 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.7 | 5.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.7 | 2.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.7 | 2.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.7 | 4.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.7 | 6.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.7 | 2.1 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.7 | 2.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.7 | 2.1 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.7 | 2.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.7 | 19.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.7 | 2.1 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.7 | 6.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.7 | 4.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.7 | 10.1 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.7 | 2.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.7 | 6.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.7 | 6.6 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.7 | 4.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.7 | 3.3 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.7 | 2.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.7 | 3.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.6 | 1.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.6 | 1.9 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.6 | 9.7 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.6 | 9.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.6 | 5.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.6 | 2.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.6 | 3.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.6 | 6.3 | GO:0005497 | androgen binding(GO:0005497) |
| 0.6 | 4.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.6 | 2.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.6 | 2.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.6 | 4.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.6 | 2.5 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.6 | 11.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.6 | 4.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.6 | 4.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.6 | 3.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.6 | 2.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.6 | 4.9 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.6 | 1.8 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.6 | 6.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.6 | 4.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.6 | 1.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.6 | 5.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.6 | 3.0 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.6 | 1.8 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.6 | 1.8 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.6 | 8.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.6 | 2.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.6 | 2.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.6 | 1.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.6 | 4.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.6 | 2.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.6 | 1.2 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.6 | 3.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.6 | 13.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.6 | 2.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.6 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.6 | 6.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.6 | 2.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.6 | 1.7 | GO:0030395 | lactose binding(GO:0030395) |
| 0.6 | 3.3 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.6 | 14.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.6 | 2.2 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 0.6 | 1.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
| 0.5 | 11.5 | GO:0071617 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.5 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.5 | 23.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.5 | 3.8 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.5 | 9.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.5 | 3.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.5 | 4.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.5 | 5.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.5 | 2.7 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.5 | 3.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.5 | 0.5 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.5 | 7.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.5 | 11.8 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.5 | 2.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.5 | 1.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.5 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.5 | 1.6 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.5 | 1.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.5 | 2.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.5 | 4.8 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.5 | 3.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.5 | 3.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.5 | 2.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.5 | 1.1 | GO:0070026 | nitric oxide binding(GO:0070026) |
| 0.5 | 2.6 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.5 | 15.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.5 | 1.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.5 | 2.1 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.5 | 4.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.5 | 1.6 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.5 | 2.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.5 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.5 | 0.5 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.5 | 2.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.5 | 6.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.5 | 1.5 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.5 | 2.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.5 | 2.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.5 | 1.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.5 | 2.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.5 | 6.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.5 | 1.5 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.5 | 2.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.5 | 11.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.5 | 9.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.5 | 1.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.5 | 3.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.5 | 3.4 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.5 | 2.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.5 | 1.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.5 | 1.5 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.5 | 2.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.5 | 1.4 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.5 | 0.5 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.5 | 2.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.5 | 1.9 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.5 | 3.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.5 | 3.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.5 | 1.4 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.5 | 3.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.5 | 6.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.5 | 17.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.5 | 1.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.5 | 8.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.5 | 1.4 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.5 | 2.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.5 | 3.3 | GO:0070404 | NADH binding(GO:0070404) |
| 0.5 | 1.4 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.5 | 1.9 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.5 | 7.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.5 | 13.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.5 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
| 0.5 | 1.8 | GO:0004803 | transposase activity(GO:0004803) |
| 0.5 | 2.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.5 | 2.3 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.5 | 2.8 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.5 | 1.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.5 | 2.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.5 | 5.4 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.5 | 3.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.5 | 1.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.5 | 5.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.4 | 9.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.4 | 6.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 1.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.4 | 2.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.4 | 1.3 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.4 | 1.3 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.4 | 1.3 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.4 | 7.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.4 | 9.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.4 | 3.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.4 | 1.8 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.4 | 2.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.4 | 10.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.4 | 1.8 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.4 | 2.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.4 | 1.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.4 | 2.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.4 | 1.7 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.4 | 1.3 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.4 | 15.7 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.4 | 7.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.4 | 2.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.4 | 2.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.4 | 1.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.4 | 1.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.4 | 9.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.4 | 4.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.4 | 2.5 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.4 | 1.7 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.4 | 5.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.4 | 1.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.4 | 2.5 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.4 | 1.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.4 | 1.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.4 | 1.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.4 | 1.7 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.4 | 2.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.4 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.4 | 1.6 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.4 | 1.2 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.4 | 2.9 | GO:0070513 | death domain binding(GO:0070513) |
| 0.4 | 2.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.4 | 2.4 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.4 | 0.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.4 | 1.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.4 | 5.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.4 | 0.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.4 | 6.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.4 | 1.6 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.4 | 3.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.4 | 5.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.4 | 19.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.4 | 1.2 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.4 | 7.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.4 | 1.6 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.4 | 1.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.4 | 3.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.4 | 1.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.4 | 3.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.4 | 3.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.4 | 3.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.4 | 19.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.4 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.4 | 2.7 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.4 | 2.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.4 | 3.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.4 | 1.2 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.4 | 3.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 4.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.4 | 1.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.4 | 2.7 | GO:0004904 | interferon receptor activity(GO:0004904) |
| 0.4 | 1.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.4 | 1.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.4 | 4.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.4 | 1.5 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.4 | 0.4 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.4 | 1.1 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.4 | 1.1 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.4 | 3.0 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.4 | 2.6 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.4 | 1.5 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.4 | 0.4 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.4 | 1.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.4 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.4 | 2.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.4 | 0.7 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.4 | 3.3 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.4 | 0.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.4 | 6.9 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.4 | 2.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.4 | 1.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.4 | 1.5 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.4 | 1.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 1.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.4 | 2.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.4 | 1.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.4 | 0.4 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.4 | 3.6 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.4 | 2.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 2.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.4 | 1.8 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.4 | 1.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.4 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.4 | 1.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.3 | 1.7 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.3 | 3.1 | GO:0009374 | biotin binding(GO:0009374) |
| 0.3 | 1.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.3 | 1.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.3 | 1.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.3 | 1.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.3 | 9.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.3 | 15.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.3 | 2.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.3 | 2.0 | GO:0052847 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.3 | 1.0 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.3 | 9.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 2.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.3 | 0.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.3 | 5.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.3 | 1.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.3 | 3.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.3 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.3 | 2.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.3 | 14.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.3 | 1.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.3 | 1.0 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.3 | 6.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 1.0 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 0.3 | 1.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.3 | 2.0 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.3 | 9.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.3 | 2.6 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.3 | 1.3 | GO:0004325 | ferrochelatase activity(GO:0004325) |
| 0.3 | 0.7 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.3 | 1.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.3 | 4.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.3 | 1.6 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.3 | 3.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.3 | 2.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.3 | 1.3 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.3 | 1.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.3 | 8.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.3 | 3.2 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.3 | 0.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.3 | 1.0 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
| 0.3 | 1.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 3.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.3 | 1.6 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.3 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.3 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.3 | 7.0 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.3 | 1.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.3 | 3.5 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.3 | 11.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.3 | 1.0 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 0.3 | 2.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.3 | 1.3 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.3 | 2.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 0.9 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.3 | 5.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.3 | 0.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.3 | 1.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.3 | 2.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.3 | 0.6 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.3 | 1.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.3 | 2.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.3 | 0.9 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.3 | 1.9 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.3 | 6.8 | GO:0016918 | retinal binding(GO:0016918) |
| 0.3 | 28.6 | GO:0033558 | protein deacetylase activity(GO:0033558) |
| 0.3 | 6.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.3 | 1.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.3 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.3 | 1.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.3 | 18.0 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.3 | 0.9 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.3 | 1.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 0.3 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.3 | 0.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.3 | 5.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 2.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.3 | 0.9 | GO:0070260 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 0.3 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.3 | 2.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.3 | 1.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.3 | 3.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 0.3 | 1.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.3 | 3.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.3 | 47.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 1.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.3 | 2.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.3 | 0.9 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.3 | 2.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.3 | 11.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.3 | 1.2 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 2.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.3 | 5.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.3 | 0.9 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.3 | 12.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.3 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.3 | 4.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.3 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.3 | 2.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.3 | 4.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.3 | 0.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.3 | 4.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.3 | 0.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.3 | 8.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.3 | 0.9 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 5.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.3 | 0.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.3 | 2.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.3 | 5.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 0.9 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.3 | 13.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.3 | 1.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 2.3 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.3 | 1.7 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.3 | 0.8 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.3 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 1.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.3 | 3.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.3 | 0.8 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.3 | 4.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
| 0.3 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.3 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.3 | 11.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.3 | 2.2 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.3 | 3.3 | GO:0005537 | mannose binding(GO:0005537) |
| 0.3 | 1.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.3 | 9.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.3 | 2.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.3 | 1.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.3 | 2.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.3 | 8.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.3 | 1.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.3 | 4.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.3 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.3 | 0.5 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.3 | 1.6 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.3 | 1.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.3 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.3 | 2.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.3 | 1.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.3 | 1.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.3 | 2.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 1.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.3 | 12.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.3 | 7.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.3 | 2.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 2.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.3 | 1.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.3 | 5.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.3 | 1.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.3 | 0.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 11.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.3 | 1.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.3 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.3 | 16.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.3 | 1.0 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.3 | 1.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.3 | 0.3 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 0.8 | GO:0032181 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.3 | 0.8 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.3 | 0.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.3 | 2.3 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.3 | 0.5 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 2.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.3 | 0.8 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.3 | 1.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.3 | 1.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.3 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.3 | 1.3 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.3 | 1.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.3 | 6.5 | GO:0043236 | laminin binding(GO:0043236) |
| 0.3 | 2.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 3.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 9.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 0.7 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.2 | 5.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 1.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 2.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 1.0 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.2 | 1.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 11.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.2 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 5.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.2 | 1.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 2.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.2 | 10.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 26.0 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.2 | 1.0 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.2 | 1.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.2 | 3.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 0.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.2 | 5.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 1.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.2 | 5.5 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 0.7 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.2 | 0.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 0.2 | 10.0 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 0.7 | GO:0001847 | opsonin receptor activity(GO:0001847) complement component C5a receptor activity(GO:0004878) |
| 0.2 | 1.9 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.2 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 2.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 2.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.2 | 0.9 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.2 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.2 | 1.6 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.2 | 1.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 1.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.2 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.2 | 2.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.2 | 2.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.2 | 4.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.2 | 1.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.2 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.2 | 0.7 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.2 | 0.7 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 15.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.2 | 0.9 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.2 | 3.6 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.2 | 8.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 1.6 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.2 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.2 | 21.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.2 | 0.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.2 | 0.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 1.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.2 | 1.5 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.2 | 2.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 1.7 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 1.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.2 | 6.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.2 | 0.9 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.2 | 0.4 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 2.4 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.2 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.2 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 1.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.2 | 2.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 1.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.2 | 1.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.2 | 0.6 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.2 | 2.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.2 | 6.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 1.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.2 | 2.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.2 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.2 | 2.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.2 | 3.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 1.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.2 | 2.9 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 1.6 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.2 | 4.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.2 | 8.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 0.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.2 | 6.7 | GO:0051287 | NAD binding(GO:0051287) |
| 0.2 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.2 | 0.6 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.2 | 2.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.2 | 1.0 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.2 | 2.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 0.6 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.2 | 0.2 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.2 | 0.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.2 | 1.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.2 | 0.6 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.2 | 1.2 | GO:0015093 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) ferrous iron transmembrane transporter activity(GO:0015093) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.2 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.2 | 1.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 0.2 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
| 0.2 | 3.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.2 | 7.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.2 | 6.3 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.2 | 0.2 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.2 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.2 | 1.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 20.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.2 | 1.0 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.2 | 0.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 10.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.2 | 0.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.2 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.2 | 2.2 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 3.7 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.2 | 0.6 | GO:0032142 | single guanine insertion binding(GO:0032142) single thymine insertion binding(GO:0032143) |
| 0.2 | 2.8 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.2 | 8.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.2 | 0.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.2 | 3.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 1.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.2 | 10.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.2 | 1.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.2 | 2.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 0.5 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.2 | 0.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.2 | 0.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.2 | 3.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.2 | 3.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 0.4 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.2 | 2.0 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 0.5 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.2 | 16.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.2 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.2 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.2 | 0.5 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.2 | 0.5 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.2 | 1.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.2 | 1.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.2 | 5.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 3.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 2.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.2 | 1.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 0.5 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.2 | 1.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.2 | 0.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.2 | 1.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.2 | 2.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.2 | 2.6 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.2 | 27.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.2 | 5.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.2 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.2 | 23.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.2 | 0.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.2 | 1.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.2 | 0.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.2 | 0.7 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 0.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.2 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 0.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.2 | 5.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.2 | 2.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 0.8 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.2 | 1.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.2 | 1.3 | GO:0016405 | CoA-ligase activity(GO:0016405) |
| 0.2 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 4.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.2 | 1.0 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.2 | 0.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.2 | 2.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.2 | 0.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.2 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
| 0.2 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.2 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.2 | 22.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 0.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.2 | 0.5 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.2 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 0.6 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.2 | 0.5 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.2 | 9.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 2.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.3 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 0.2 | 0.5 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.2 | 0.9 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.2 | 4.1 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.2 | 2.7 | GO:0043531 | ADP binding(GO:0043531) |
| 0.2 | 0.5 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.2 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 2.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 0.8 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.2 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 1.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.1 | 3.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.1 | 25.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 34.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.9 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.1 | 1.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.1 | 4.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.1 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.1 | 2.8 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.1 | 12.5 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 3.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
| 0.1 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 0.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.1 | 8.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 4.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.1 | 0.4 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 1.8 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.1 | 64.0 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.1 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.1 | 11.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 1.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 0.1 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.1 | 2.5 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
| 0.1 | 2.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.1 | 1.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 0.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 2.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 0.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.1 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.7 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.1 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 1.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 0.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.1 | 0.3 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.1 | 4.8 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.1 | 0.3 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 0.4 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.1 | 0.7 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.1 | 0.5 | GO:0032406 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.1 | 18.5 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 0.8 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 2.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.1 | 2.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 7.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 2.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 2.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 4.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
| 0.1 | 0.3 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 2.2 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.1 | 20.1 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 2.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 1.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 1.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 8.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.9 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 0.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
| 0.1 | 0.9 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.1 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.5 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.1 | 1.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 1.1 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 0.5 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.1 | 0.2 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.1 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 13.8 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.1 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.1 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 0.2 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 0.1 | 0.6 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.1 | 1.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 1.6 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.1 | 0.4 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.1 | 0.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 3.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 4.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 0.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 0.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 2.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 1.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 0.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 0.8 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.1 | 0.4 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 1.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.1 | 0.3 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.1 | 0.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 2.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.1 | 3.2 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 0.3 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.1 | 0.7 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
| 0.1 | 3.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.1 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.1 | 1.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 1.1 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.1 | 25.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 1.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 5.3 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
| 0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 2.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.1 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.4 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.1 | 1.0 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.1 | 0.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.1 | 0.6 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 1.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 2.9 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 5.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
| 0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 0.3 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.1 | 3.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.1 | 0.8 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.1 | 0.7 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.1 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.1 | 0.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.1 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.1 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.1 | 0.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.1 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 4.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 2.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 2.0 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.1 | 1.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 1.0 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 0.3 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.1 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 1.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 2.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 1.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.1 | 0.8 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.1 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 1.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 1.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 0.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 0.3 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 109.7 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 3.3 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 4.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.1 | 0.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 0.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 4.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.1 | 0.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 6.3 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 2.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.2 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 1.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.4 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 14.2 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.1 | 0.1 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.1 | 2.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.1 | 1.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 0.5 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.1 | 0.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.1 | 0.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.1 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 6.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.1 | 0.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.1 | 0.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.1 | 0.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 5.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.1 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.1 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.1 | 0.2 | GO:0050661 | NADP binding(GO:0050661) |
| 0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 0.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 2.2 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 0.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
| 0.1 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.1 | 0.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.1 | 1.3 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.1 | 3.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.1 | 10.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.1 | 4.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.1 | 1.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.1 | 0.6 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 0.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.1 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 0.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.0 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.0 | 0.2 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
| 0.0 | 0.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.0 | 2.0 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.0 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.0 | 10.9 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.0 | 0.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.0 | 0.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 1.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.2 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.0 | 0.1 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
| 0.0 | 0.9 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
| 0.0 | 0.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.0 | 2.0 | GO:0004175 | endopeptidase activity(GO:0004175) |
| 0.0 | 1.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.0 | 7.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 3.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.0 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.0 | 1.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
| 0.0 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.0 | 0.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 35.5 | GO:0003677 | DNA binding(GO:0003677) |
| 0.0 | 3.5 | GO:0003676 | nucleic acid binding(GO:0003676) |
| 0.0 | 1.0 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.0 | 0.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.0 | 2.0 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.0 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 1.6 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
| 0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.2 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 3.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.0 | 0.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
| 0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.0 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.0 | 1.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.0 | 0.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.0 | 0.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 1.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
| 0.0 | 2.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.3 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 21.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 1.0 | 1.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.9 | 0.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.8 | 2.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.7 | 0.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.6 | 43.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.5 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.5 | 9.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.5 | 31.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.5 | 28.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.5 | 3.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.5 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.5 | 27.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.5 | 29.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.4 | 0.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.4 | 13.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.4 | 3.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.4 | 18.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.4 | 44.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.4 | 9.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.4 | 18.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.4 | 28.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.4 | 34.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.4 | 1.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.4 | 21.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.4 | 32.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.4 | 18.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.3 | 4.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.3 | 2.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 6.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 9.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.3 | 17.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.3 | 6.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.3 | 1.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.3 | 9.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.3 | 5.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 1.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.3 | 3.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.3 | 8.3 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 12.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
| 0.3 | 1.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.3 | 10.1 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.3 | 10.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.3 | 36.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.3 | 8.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.3 | 12.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.2 | 1.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 10.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.2 | 2.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 9.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.2 | 11.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 25.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.2 | 4.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.2 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.2 | 7.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 3.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 11.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 12.2 | PID FOXO PATHWAY | FoxO family signaling |
| 0.2 | 7.5 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 3.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.2 | 11.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.2 | 10.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 15.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.2 | 1.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 14.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 4.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 25.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 3.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 2.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 11.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 1.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 1.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.2 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 9.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.2 | 2.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 2.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 50.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 2.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 10.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.2 | 8.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.2 | 2.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 8.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 15.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 1.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.1 | 8.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 1.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 2.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 37.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 3.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 6.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 5.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 2.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 9.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 4.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 3.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 10.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 3.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 1.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.1 | 1.2 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 4.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 1.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.8 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 2.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 2.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 0.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 2.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 3.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 12.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 1.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.0 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 1.6 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
| 1.1 | 1.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 1.1 | 24.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.9 | 34.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.9 | 14.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.9 | 10.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.8 | 38.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.8 | 7.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.7 | 17.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.7 | 33.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.6 | 11.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.6 | 6.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.6 | 8.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.6 | 37.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.6 | 27.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.5 | 15.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.5 | 3.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.5 | 11.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.5 | 3.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.5 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.5 | 21.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.5 | 26.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.5 | 12.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.4 | 12.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.4 | 10.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.4 | 8.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.4 | 27.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.4 | 0.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.4 | 12.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.4 | 10.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.4 | 15.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.4 | 5.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.4 | 9.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.4 | 14.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.4 | 9.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.4 | 29.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.4 | 15.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.4 | 3.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.3 | 5.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.3 | 6.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 3.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.3 | 4.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.3 | 32.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.3 | 11.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.3 | 3.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.3 | 11.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.3 | 29.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.3 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.3 | 34.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.3 | 8.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.3 | 26.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.3 | 3.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.3 | 3.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.3 | 5.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 9.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.3 | 13.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.3 | 2.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.3 | 6.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 8.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.3 | 14.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.3 | 4.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.3 | 4.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.3 | 11.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.3 | 3.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.3 | 6.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.3 | 6.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.3 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.3 | 3.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.3 | 4.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.3 | 2.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.3 | 3.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.3 | 9.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.3 | 2.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.3 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.3 | 4.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.3 | 1.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.3 | 2.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.3 | 8.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 6.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 5.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.2 | 13.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 4.5 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.2 | 7.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.2 | 10.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.2 | 7.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.2 | 20.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 6.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 10.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.2 | 18.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.2 | 0.7 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.2 | 6.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.2 | 10.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 6.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.2 | 16.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 5.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 1.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 0.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.2 | 5.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.2 | 11.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 12.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 6.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.2 | 4.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 27.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.2 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.2 | 8.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 30.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 2.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.2 | 2.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 4.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.2 | 2.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.2 | 13.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.2 | 4.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 4.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 2.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.2 | 7.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.2 | 6.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 2.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 0.9 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
| 0.2 | 2.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.2 | 0.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.2 | 2.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.2 | 5.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.2 | 3.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.2 | 11.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.2 | 4.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 2.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.2 | 4.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.2 | 3.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 6.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 3.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 13.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 15.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 4.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.1 | 4.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 1.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 7.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 6.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 5.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 7.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 4.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 9.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.1 | 4.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.1 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 0.5 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
| 0.1 | 1.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 0.1 | 1.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 4.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 3.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 4.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.1 | 5.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.1 | 2.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 7.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.1 | 1.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 18.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 8.9 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 0.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 9.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 3.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.1 | 1.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 0.9 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.1 | 0.6 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
| 0.1 | 1.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 9.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 3.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 3.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 1.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 0.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.1 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 2.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 2.7 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.1 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 2.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 1.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 5.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 1.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 2.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 3.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 2.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 5.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.1 | 1.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 2.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 4.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 2.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.1 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 22.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.1 | 4.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 10.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 6.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 9.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 0.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 0.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 6.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 9.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 1.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.0 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 1.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 1.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 1.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.0 | 0.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 5.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 3.9 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.0 | 2.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.5 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 0.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |